Annette Westgeest

39 Barriers in the uptake of MRSA ‘search and destroy’ 2 In case of treatment yourself, which treatment do you prescribe? Mupirocin nose cream + disinfecting soap + hygienic measures The above in combination with systemic antibiotics Other: …………………………………………………………… Appendix B. GP’s responses to clinical cases Frequency n/n (%) Case A. Treatment of uncomplicated carriership No eradication treatment 37/114 (33) Treatment by GP 17/114 (15) Topical therapy + hygienic measures 12/17 (71) Topical therapy + hygienic measures + systemic therapy 4/17 (24) Other 1/17 (6) Referral to hospital/MRSA clinic 15/114 (13) Consultation with specialist 29/114 (25) Other 15/114 (13) Case B. Treatment of complicated carriership No eradication treatment 3/114 (3) Treatment by GP 14/114 (12) Topical therapy + hygienic measures 4/14 (29) Topical therapy + hygienic measures + systemic therapy 8/14 (57) Other 2/14 (14) Referral to hospital/MRSA clinic 56/114 (49) Consultation with specialist 31/114 (27) Other 10/114 (9) Legend. Case A. A 26 years-old healthy male was admitted in the hospital during a holiday in Spain because of a trauma. After returning in the Netherlands, you perform culture swabs from nose, throat and perineum. The nasal culture is positive for MRSA. There are no skin lesions. There are no hospital visits planned. Case B. A 56 years-old male with a history of heart failure and chronic kidney disease, was screened for MRSA carriership by you following a hospital admission. He is MRSA positive in nose, throat and perineum.

RkJQdWJsaXNoZXIy MTk4NDMw